Search Results - "Wogensen, L"

Refine Results
  1. 1

    Erythropoietin administration is associated with short-term improvement in glomerular filtration rate after ischemia-reperfusion injury by SØLLING, C., CHRISTENSEN, A. T., KRAG, S., FRØKIÆR, J., WOGENSEN, L., KROG, J., TØNNESEN, E. K.

    Published in Acta anaesthesiologica Scandinavica (01-02-2011)
    “…Background: Erythropoietin (EPO) is a cytokine with organ‐protective properties. We hypothesized that EPO could attenuate acute renal dysfunction and…”
    Get full text
    Journal Article
  2. 2

    Erythropoietin does not attenuate renal dysfunction or inflammation in a porcine model of endotoxemia by SØLLING, C., CHRISTENSEN, A. T., NYGAARD, U., KRAG, S., FRØKIÆR, J., WOGENSEN, L., KROG, J., TØNNESEN, E. K.

    Published in Acta anaesthesiologica Scandinavica (01-04-2011)
    “…Background: Erythropoietin (EPO) is a multifunctional cytokine with anti‐apoptotic, anti‐inflammatory, and organ protective effects. EPO protects against…”
    Get full text
    Journal Article
  3. 3

    Does brain death induce a pro-inflammatory response at the organ level in a porcine model? by BARKLIN, A., LARSSON, A., VESTERGAARD, C., KOEFOED-NIELSEN, J., BACH, A., NYBOE, R., WOGENSEN, L., TØNNESEN, E.

    Published in Acta anaesthesiologica Scandinavica (01-05-2008)
    “…Background: Organs from brain‐dead donors have a poorer prognosis after transplantation than organs from living donors. A possible explanation for this is that…”
    Get full text
    Journal Article
  4. 4

    Insulin alters cytokine content in two pivotal organs after brain death: a porcine model by BARKLIN, A., LARSSON, A., VESTERGAARD, C., KJAERGAARD, A., WOGENSEN, L., SCHMITZ, O., TØNNESEN, E.

    Published in Acta anaesthesiologica Scandinavica (01-05-2008)
    “…Background: To optimize the quantity and quality of organs available for transplantation, it is crucial to gain further insight into the treatment of brain…”
    Get full text
    Journal Article
  5. 5

    Renal cytokine profile in an endotoxemic porcine model by GRANFELDT, A., EBDRUP, L., TØNNESEN, E., WOGENSEN, L.

    Published in Acta anaesthesiologica Scandinavica (01-05-2008)
    “…Introduction: In animals exposed to acute endotoxemia with lipopolysaccharide (LPS), high levels of cytokines are found in the kidney. The objective of this…”
    Get full text
    Journal Article
  6. 6

    Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice by WOGENSEN, L, MYUNG-SHIK LEE, SARVETNICK, N

    Published in The Journal of experimental medicine (01-04-1994)
    “…The T helper type 2 (Th2) cell product interleukin 10 (IL-10) inhibits the proliferation and function of Th1 lymphocytes and macrophages (M phi). The nonobese…”
    Get full text
    Journal Article
  7. 7

    Real-time PCR: housekeeping genes in the INS-1E beta-cell line by Smidt, K, Wogensen, L, Brock, B, Schmitz, O, Rungby, J

    Published in Hormone and metabolic research (01-01-2006)
    “…Investigation of gene expression is a developing area with several methods available. One method is quantitative PCR. A major pitfall in quantitative PCR is…”
    Get more information
    Journal Article
  8. 8

    The use of transgenic animals in the study of diabetic kidney disease by Wogensen, L, Krag, S, Chai, Q, Ledet, T

    Published in Hormone and metabolic research (01-04-2005)
    “…Diabetic nephropathy is one of the most common diseases leading to fibrosis and end-stage renal disease (ESRD) world wide. Under normal conditions, a delicate…”
    Get more information
    Journal Article
  9. 9

    Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction by Gu, D, Wogensen, L, Calcutt, N A, Xia, C, Zhu, S, Merlie, J P, Fox, H S, Lindstrom, J, Powell, H C, Sarvetnick, N

    Published in The Journal of experimental medicine (01-02-1995)
    “…Abnormal humoral responses toward motor end plate constituents in muscle induce myasthenia gravis (MG). To study the etiology of this disease, and whether it…”
    Get full text
    Journal Article
  10. 10

    Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury by Mandrup-Poulsen, Thomas, Wogensen, Lise D, Jensen, Michael, Svensson, Preben, Nilsson, Povl, Emdal, Thorkil, Molvig, Jens, Dinarello, Charles A, Nerup, Jorn

    Published in Critical care medicine (01-01-1995)
    “…OBJECTIVETo investigate the balance between circulating concentrations of interleukin (IL)-1 and its natural inhibitor interleukin-1 receptor antagonist…”
    Get full text
    Journal Article
  11. 11

    Mechanisms of pancreatic beta-cell destruction in type I diabetes by Nerup, J, Mandrup-Poulsen, T, Mølvig, J, Helqvist, S, Wogensen, L, Egeberg, J

    Published in Diabetes care (01-11-1988)
    “…The pathogenetic mechanisms leading to beta-cell destruction and insulin-dependent diabetes mellitus (IDDM) are major histocompatibility complex (MHC)…”
    Get full text
    Journal Article
  12. 12
  13. 13

    A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus by Pociot, F, Mølvig, J, Wogensen, L, Worsaae, H, Dalbøge, H, Baek, L, Nerup, J

    Published in Scandinavian journal of immunology (01-01-1991)
    “…HLA-class III region genes may be associated with susceptibility to insulin-dependent diabetes mellitus (IDDM). In this study an NcoI polymorphism of the…”
    Get more information
    Journal Article
  14. 14

    Pancreatic beta-cell function and interleukin-1 beta in plasma during the acute phase response in patients with major burn injuries by Wogensen, L, Jensen, M, Svensson, P, Worsaae, H, Welinder, B, Nerup, J

    Published in European journal of clinical investigation (01-05-1993)
    “…Animal experiments demonstrate that interleukin-1 beta (IL-1 beta) is beta-cell cytotoxic in vitro and inhibits insulin secretion in vivo. However, it is…”
    Get more information
    Journal Article
  15. 15

    Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice by Wogensen, L, Nielsen, C B, Hjorth, P, Rasmussen, L M, Nielsen, A H, Gross, K, Sarvetnick, N, Ledet, T

    Published in Diabetes (New York, N.Y.) (01-01-1999)
    “…Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic…”
    Get full text
    Journal Article
  16. 16

    Repetitive in vivo treatment with human recombinant interleukin-1β modifies Beta-cell function in normal rats by WOGENSEN, L. D, REIMERS, J, NERUP, J, KOLB-BACHOFEN, V, KRÖNCKE, K.-D, ALMDAL, T, MANDRUP-POULSEN, T

    Published in Diabetologia (01-04-1992)
    “…It is unknown whether interleukin-1 exerts a bimodal effect on Beta-cell function in vivo, and whether interleukin-1 has a diabetogenic action in normal…”
    Get full text
    Journal Article
  17. 17

    The pharmacokinetics, distribution and degradation of human recombinant interleukin 1 beta in normal rats by Reimers, J, Wogensen, L D, Welinder, B, Hejnaes, K R, Poulsen, S S, Nilsson, P, Nerup, J

    Published in Scandinavian journal of immunology (01-11-1991)
    “…Based upon in vivo rat experiments it was recently suggested that interleukin 1 in the circulation may be implicated in the initial events of beta-cell…”
    Get more information
    Journal Article
  18. 18

    Monocyte function in IDDM patients and healthy individuals by Mølvig, J, Pociot, F, Baek, L, Worsaae, H, Dall Wogensen, L, Christensen, P, Staub-Nielsen, L, Mandrup-Poulsen, T, Manogue, K, Nerup, J

    Published in Scandinavian journal of immunology (01-09-1990)
    “…Interleukin 1 beta (IL-1 beta) and tumour necrosis factor alpha (TNF-alpha) may be pathogenetically important in insulin-dependent diabetes mellitus (IDDM),…”
    Get more information
    Journal Article
  19. 19

    Functional and morphological effects of interleukin-1 beta on the perfused rat pancreas by Wogensen, L D, Kolb-Bachofen, V, Christensen, P, Dinarello, C A, Mandrup-Poulsen, T, Martin, S, Nerup, J

    Published in Diabetologia (01-01-1990)
    “…We recently reported a potentiating effect of recombinant human interleukin-1 beta on glucose-stimulated insulin release from the isolated perfused pancreas…”
    Get full text
    Journal Article
  20. 20

    Plasminogen activator inhibitor-1 gene deficiency attenuates TGF- beta 1-induced kidney disease by Krag, Soeren, Danielsen, Carl Christian, Carmeliet, Peter, Nyengaard, Jens, Wogensen, Lise

    Published in Kidney international (01-12-2005)
    “…Background. Transforming growth factor- beta 1 (TGF- beta 1) stimulates the deposition of extracellular matrix (ECM), which is a hallmark in end-stage renal…”
    Get full text
    Journal Article